USE OF A NON-NATURALLY-OCCURRING EP1 SELECTIVE AGONIST FOR INCREASING BONE VOLUME - Patent 1158969

(19)

(11)

EP 1 158 969 A2

(12)

(88)	Date of publication A3:
	25.01.2001

(43)	Date of publication:
	05.12.2001 Bulletin 2001/49

(21)	Application number: 00915937.7

(22)	Date of filing: 01.03.2000

(51)	International Patent Classification (IPC)⁷: A61K 31/00, A61K 31/5575, A61P 19/08, A61P 19/10

(86)	International application number:
	PCT/US0005/196

(87)	International publication number:
	WO 0051/585 (08.09.2000 Gazette 2000/36)

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	AL LT LV MK RO SI

(30)

Priority:

05.03.1999 US 123063 P

(71)	Applicant: The Procter & Gamble Company
	Cincinnati,Ohio 45202 (US)

(72)	Inventors:
	HARTKE, James, Richard West Chester, OH 45069 (US) LUNDY, Mark, Walden Cincinnati, OH 45241 (US) DELONG, Mitchell, Anthony West Chester, OH 45069 (US)

(74)	Representative: Clemo, Nicholas Graham et al
	Patent Department,Procter & Gamble Technical Centres Limited,Rusham Park,Whitehall Lane Egham, Surrey TW20 9NW Egham, Surrey TW20 9NW (GB)

(54)	USE OF A NON-NATURALLY-OCCURRING EP1 SELECTIVE AGONIST FOR INCREASING BONE VOLUME